Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Clements

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Arthritis and Rheumatism|June 10, 2004
Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosisPhilip J Clements, Jonathan G Goldin, Eric C Kleerup, et al.
The Journal of Rheumatology|June 3, 2015
Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life StudySarah D Mills, Rina S Fox, Erin L Merz, et al.
Annals of the Rheumatic Diseases|October 15, 2011
The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAHPhilip J Clements, Mary Tan, Vallerie V McLaughlin, et al.
Rheumatology (Oxford, England)|July 17, 2009
Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trialsMarian Kaldas, Puja P Khanna, Daniel E Furst, et al.
Chest|August 23, 2012
Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gapVallerie V McLaughlin, Anatoly Langer, Mary Tan, et al.
The Journal of Rheumatology|July 5, 2011
Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentDinesh Khanna, Daniel E Furst, Paul Maranian, et al.
Rheumatology (Oxford, England)|October 2, 2010
Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosisVijay Bodukam, Ron D Hays, Paul Maranian, et al.
Case Reports in Rheumatology|November 8, 2014
Acute hemorrhagic myositis in inflammatory myopathy and review of the literatureHoward Van Gelder, Kim M Wu, Nayiri Gharibian, et al.
ACR Open Rheumatology|May 21, 2020
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study IIElizabeth R Volkmann, Donald P Tashkin, Holly LeClair, et al.
Arthritis and Rheumatism|July 20, 2011
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung diseaseDinesh Khanna, Rajeev Saggar, Maureen D Mayes, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Arthritis and Rheumatism|June 10, 2004
Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosisPhilip J Clements, Jonathan G Goldin, Eric C Kleerup, et al.
The Journal of Rheumatology|June 3, 2015
Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life StudySarah D Mills, Rina S Fox, Erin L Merz, et al.
Annals of the Rheumatic Diseases|October 15, 2011
The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAHPhilip J Clements, Mary Tan, Vallerie V McLaughlin, et al.
Rheumatology (Oxford, England)|July 17, 2009
Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trialsMarian Kaldas, Puja P Khanna, Daniel E Furst, et al.
Chest|August 23, 2012
Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gapVallerie V McLaughlin, Anatoly Langer, Mary Tan, et al.
The Journal of Rheumatology|July 5, 2011
Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentDinesh Khanna, Daniel E Furst, Paul Maranian, et al.
Rheumatology (Oxford, England)|October 2, 2010
Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosisVijay Bodukam, Ron D Hays, Paul Maranian, et al.
Case Reports in Rheumatology|November 8, 2014
Acute hemorrhagic myositis in inflammatory myopathy and review of the literatureHoward Van Gelder, Kim M Wu, Nayiri Gharibian, et al.
ACR Open Rheumatology|May 21, 2020
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study IIElizabeth R Volkmann, Donald P Tashkin, Holly LeClair, et al.
Arthritis and Rheumatism|July 20, 2011
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung diseaseDinesh Khanna, Rajeev Saggar, Maureen D Mayes, et al.
Pageof 10